TOFACITINIB CITRATE (TOFACITINIB CITRATE) — FDA Approval ANDA209633 (BRECKENRIDGE)
TOFACITINIB CITRATE (TOFACITINIB CITRATE) — FDA Approval ANDA209633 (BRECKENRIDGE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TOFACITINIB CITRATE; Active ingredients: TOFACITINIB CITRATE; Application number: ANDA209633.
| Brand name | TOFACITINIB CITRATE |
|---|---|
| Active ingredients | TOFACITINIB CITRATE |
| Application number | ANDA209633 |
| Sponsor | BRECKENRIDGE |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20260603 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →